AKBA Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $1.39 = $13.9
AKBA Charts
AKBA Prices
View the AKBA historical prices.
52WL $0.59
The 52 Week Low is $0.59 set on Wed, Apr 5, 2023.
52WH $2.48
The 52 Week High is $2.48 set on Tue, Aug 1, 2023. The current price, $1.39, is 0% below the 52 Week High.
ATH $31.00
The All-Time High is $31.00 set on Fri, Jun 20, 2014. The current price, $1.39, is 0% below the All Time High.
52 Week Range
AKBA Dividends
AKBA has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
AKBA Profile
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes 1) Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease. 2) Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients. 3) HIF-PH inhibitors in preclinical development.
